Collagen Solutions company
Collagen Solutions Plc is a global provider of medical grade collagen formulations and components for use in regenerative medicine, medical devices and in-vitro diagnostics.
Our capabilities include the provision of native, soluble and powdered collagen formulations and expertise in the development and contract manufacture of collagen components for use as tissue scaffolds and medical devices.
Collagen Solutions' unique offering extends beyond material supply and contract services as our highly skilled staff support customers through various stages of development and regulatory approval, establishing long-term commercial relationships.
Total Funding:
£18M
Headquarters:
London, England, United Kingdom
Funding Status:
IPO
Employee Number:
11-50
Estimated Revenue:
$1M to $10M
Investment Stage:
N/A
Last Funding Type:
Post-IPO Equity
Number Of Exists:
Post-IPO Equity
Technology:
P4 Medicine
Investor Type:
Company
Investors Number:
2
Founded Date:
7-4
Industry:
Regenerative Medicine